teva
updat sever model ahead result base iqvia rx sale
trend corpor event rais ep estim
lower estim
bhc
teva
chang price target pleas see detail
agn tweak revenu estim base higher sale vraylar
linzess partial off-set lower sale alphagan franchis new
ep ep chang
ep
lower gener sale estim
reflect lack materi launch quarter continu model
sale ramp come quarter driven new launch rais rytari
estim higher market share assumpt new ep
ep ep
bhc base rx trend trim sale estim wellbutrin xl
xifaxan estim larg unchang new ep
ep ep
trim sale estim nucynta franchis
base slightli lower market share xtampza er estim
larg unchang new ep ep
ep chang
base strong iqvia sale growth rais quarterli sale
estim adrenalin also updat model
reflect compani recent debt financ tender offer
dilut ep new ep ep
ep
lower north america revenu estim rais
estim reflect grow contribut launch year
progress also increas sg estim reflect greater
invest ahead launch new ep
ep ep
teva trim north america estim base primarili lower
sale copaxon bendeka/treanda franchis also lower gross
margin bendeka base recent revis deal term
eagl nr new ep ep
ep
interest
revenu
page
interest
revenu
page
revenu
page
revenu
page
interest
revenu
page
interest
revenu
page
revenu
page
revenu
page
interest
revenu
page
interest
revenu
page
neuro
neuro
revenu
neuro
page
neuro
neuro
revenu
neuro
page
interest
revenu
page
interest
revenu
page
revenu
page
revenu
page
interest
revenu
page
interest
revenu
page
revenu
page
revenu
page
interest
revenu
page
interest
revenu
page
rest world
rest world
revenu
rest world
page
rest world
rest world
revenu
rest world
page
interest
minor share profit loss
dividend prefer share
revenu
page
interest
minor share profit loss
dividend prefer share
revenu
page
page
page
compani mention note
gregg gilbert herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
